How Do Antimicrobial Shortages Differ Between High- & Low-Income Countries?
Milena McLaughlin, PharmD, MSc, explains how antimicrobial shortages differ between high- and low-income countries.
Watch
What Are the Special Properties of MRSA Prodrug TXA709?
Edmond LaVoie, PhD, describes the properties of prodrug TXA709.
Rutgers Researchers Develop New MRSA Prodrug: Can the Pathogen Gain Resistance?
Daniel Pilch, PhD, discusses the potential of Staphylococcus aureus to develop resistance to TXA709.
What is the Population-based HIV Impact Assessment Project?
Jessica Justman, MD, explains the PHIA Project (population-based HIV impact assessments).
Discussing the Legal Liability of Prescribing Beta-Lactams to Penicillin-Allergic Patients
Meghan Jeffres, PharmD, discusses the legal liability of prescribing beta-lactams to patients who are allergic to penicillin.
Why Clinicians Need to Know the Challenges Associated with Getting AST Results
ason Gallagher, PharmD, BCPS FCCP, FIDSA, explains why clinicians should be aware of the challenges associated with getting antimicrobial susceptibility testing results.
Outbreaks in Operating Rooms: How Do They Happen?
Arjun Srinivasan, MD, discusses how outbreaks can occur in operating rooms.
Treating Pseudomonas: How Does Ceftolozane-Tazobactam Differ from Other Beta-Lactams?
Jason Pogue, PharmD, BCPS-ID, explains how ceftolozane-tazobactam differs from other beta-lactams for treating Pseudomonas infections.
How is Janssen's New HIV-1 Vaccine Regimen Unique?
Hanneke Schuitemaker, PhD, explains what makes Janssen’s new HIV-1 vaccine regimen unique.
How to Remain Vigilant with Antimicrobial Shortages
Milena McLaughlin, PharmD, MSc, explains ways to remain vigilant when it comes to drug shortages.
Once Labeled, Always Labeled: Addressing Misconceptions About Penicillin Allergies
Elizabeth Phillips, MD, FRCPC, FRACP, addresses the misconceptions about penicillin allergies.
What is The Utility of Penicillin Skin Testing for Patients Labeled as Penicillin Allergic?
Meghan Jeffres, PharmD, discusses the utility of penicillin skin testing for patients labeled as penicillin allergic.
What Makes Cabotegravir a Unique Medication for HIV?
Alex Rinehart, PhD, Director, Global Prevention Strategy, ViiV Healthcare, explains what makes cabotegravir a unique medication for HIV.
How Can Primary Care Providers Help Their Patients Decide if PrEP Is Right for Them?
Kenneth Mayer, MD, explains why primary care providers need to have a good sense of their patients in order to help them decide if PrEP is right for them.
Who Are the Core Partners Involved in the Fast-Track Cities Initiative?
Benjamin Young, MD, PhD, discusses the four partners behind the Fast-Track Cities Initiative.
Preventing Candida auris Infections in At-Risk Patients
Snigdha Vallabhaneni, MD, MPH, shares actions patients and their visitors can take to protect themselves from Candida auris.
New Formulation of Raltegravir HD Explained
Pedro Cahn, MD, explains the new formulation of raltegravir HD.
Treating HIV Today vs the 1980s: One Doctor's Perspective
Kathleen Squires, MD, explains how HIV treatment has changed since the 1980s.
Mother-to-Child Transmission of HIV Remains a Significant Burden
Lynne Mofenson, MD, shares an update on the health burden of mother-to-child transmission (MTCT) of HIV.
Read More
1990s to Today: How Has Generating Interest for the Response to HIV and AIDS Changed?
Jake Glaser discusses how generating interest for the response to HIV and AIDS has changed since the 1990s.
What is the LATTE-2 Trial for HIV Treatment?
Peter Williams, PhD, discusses the LATTE-2 trial for HIV treatment.
What is The Benefit of Darunavir Versus Other HIV Medications?
Magda Opsomer, MD, explains why darunavir may be more beneficial than other HIV medications.
What Makes a Biomedical Implant a Desirable Way to Administer PrEP?
Ariane van der Straten, PhD, MPH, explains the different attributes of administering pre-exposure prophylaxis via a HIV biomedical implant.
What is the Biomedical HIV Prevention Implant Being Developed by RTI?
Leah Johnson, PhD, discusses the biomedical HIV prevention implant that is being developed by RTI International.
Tenofovir Alafenamide: The Future of Pre-Exposure Prophylaxis?
Kenneth Mayer, MD, explains why tenofovir alafenamide may be the future of pre-exposure prophylaxis.
Importance of Surgical Teams Voicing Safety Concerns in Operating Rooms
Arjun Srinivasan, MD, stresses the importance of surgical teams speaking up if they have safety concerns regarding procedure in operating rooms.
Investigating Pseudomonas Susceptibility to Ceftolozane/tazobactam
Jason Pogue, PharmD, BCPS-ID, explains his team’s study regarding the susceptibility of Pseudomonas isolates to ceftolozane/tazobactam.
What is the Best Way to Determine an Alternative Agent During a Drug Shortage?
Milena McLaughlin, PharmD, MSc, explains the best way to determine an alternative agent during a drug shortage.
Can Antimicrobial Photodynamic Therapy Complement Antimicrobial Chemotherapy?
Caetano Sabino, BSc, discusses how antimicrobial photodynamic therapy could be used to complement antimicrobial chemotherapy in order to manage drug-resistant infections.
How Restrictions on Commercial Automated Susceptibility Testing Affects Patient Care
Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how restrictions on commercial automated susceptibility testing can affect patient care.